In a report issued on November 30, Charlotte Friedrichs from Berenberg Bank maintained a Buy rating on Medios AG (MEDOF), with a price target of EUR42.00. The company’s shares closed last Thursday at $1.80.
According to TipRanks.com, Friedrichs is ranked #1168 out of 7124 analysts.
Currently, the analyst consensus on Medios AG is a Strong Buy with an average price target of $53.26, which is a 2267.1% upside from current levels. In a report issued on November 25, Kepler Capital also maintained a Buy rating on the stock with a EUR34.00 price target.
See today’s analyst top recommended stocks >>
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. It operates through the following segments: Provision of Medicinal Products, Patient-specific Therapies, and Services. The Provision of Medicinal Products segment focuses on specialty pharmaceuticals means it trades almost exclusively in expensive medicinal products for chronic and/or rare diseases. The Patient-specific Therapies segment include infusions constituted and produced on the basis of individual symptoms and individual parameters such as body weight and body surface. The Services segment consists of all other Group activities, including Medios Group holding activities. The company was founded in 1980 and is headquartered in Berlin, Germany.
